Patents by Inventor Masanori KUSUMOTO

Masanori KUSUMOTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DPP-4 INHIBITOR AND PRODUCTION METHOD THEREFOR
    Publication number: 20240408185
    Abstract: An aspect of the present invention is directed to provide a novel dipeptidyl peptidase IV (DPP-4) inhibitor and a production method thereof. The DPP-4 inhibitor according to an aspect of the present invention contains a hydrolysate obtained by hydrolyzing a protein derived from a microorganism. An article according to another aspect of the present invention for preventing and/or improving abnormality involving DPP-4 contains the DPP-4 inhibitor. A method for producing the DPP-4 inhibitor according to another aspect of the present invention includes a step of hydrolyzing a protein derived from a microorganism with a protease.
    Type: Application
    Filed: November 2, 2022
    Publication date: December 12, 2024
    Applicant: SUMITOMO CHEMICAL COMPANY, LIMITED
    Inventors: Masanori KUSUMOTO, Toshihiro YONEYAMA, Mikio AOKI, Kazuki MIKATA
  • Diagnostic drug and diagnostic method for Alzheimer's disease
    Patent number: 12000844
    Abstract: The present invention provides a polypeptide consisting of any of the following amino acid sequences and useful for determining Alzheimer's disease: (1) the amino acid sequence shown in SEQ ID NO: 1; and (2) an amino acid sequence resulting from substitution, deletion, addition or insertion of one to several amino acids in the amino acid sequence shown in SEQ ID NO: 1.
    Type: Grant
    Filed: August 6, 2019
    Date of Patent: June 4, 2024
    Assignee: SUMITOMO PHARMA CO., LTD.
    Inventors: Atsushi Ono, Yasuhiro Teranishi, Masanori Kusumoto, Masakazu Hashimoto, Shoji Kashiwabara, Maki Hashimoto
  • DIAGNOSTIC DRUG AND DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE
    Publication number: 20210165002
    Abstract: The present invention provides a polypeptide consisting of any of the following amino acid sequences and useful for determining Alzheimer's disease: (1) the amino acid sequence shown in SEQ ID NO: 1; and (2) an amino acid sequence resulting from substitution, deletion, addition or insertion of one to several amino acids in the amino acid sequence shown in SEQ ID NO: 1.
    Type: Application
    Filed: August 6, 2019
    Publication date: June 3, 2021
    Applicant: Sumitomo Dainippon Pharma Co., Ltd.
    Inventors: Atsushi ONO, Yasuhiro TERANISHI, Masanori KUSUMOTO, Masakazu HASHIMOTO, Shoji KASHIWABARA, Maki HASHIMOTO